Nathan Bartlett + FOLLOW
Nathan Bartlett is Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle in Australia, and head of the Viral Immunology and Respiratory Disease group. He is based at the Hunter Medical Research Institute. He also retains an honorary academic appointment at Imperial College London, UK to continue collaborative research.
Show more
Great ideas attract $7 million in NHMRC grants miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
Research on preventative COVID-19 nasal spray published in prestigious, peer-reviewed academic journals: EBioMedicine and the European Respiratory Journal
Novel therapy developed by Australian biotech company, Ena Respiratory, shown in animal study to reduce COVID-19 virus levels in the nose and throat by up to 96%; also found to be effective against rhinovirus (common cold), the
predominant cause of the common cold and exacerbations of chronic respiratory diseases including asthma and COPD
Mode of action complementary to COVID-19 vaccines, once weekly nasal spray to play significant role in reducing COVID-19 community transmission and disease progression in at risk populations
Australian scientists are looking into a naturally occurring protein in breast milk
Lactoferrin is an immune system protein that stops virus from binding to cells
Freedom Foods partnered with Hunter Medical Research Institute to look into it
It comes a day after the University of Queensland ended its COVID vaccine trials
Deal was scrapped after participants returned false positive HIV test results